Literature DB >> 24145695

Gene-environment interaction of body mass index and apolipoprotein E ε4 allele on cognitive decline.

Kumar B Rajan1, Kimberly A Skarupski, Heather E Rasmussen, Denis A Evans.   

Abstract

Genetic variation alone may not account for common chronic disease susceptibility. Rather, an interaction between genetic and environmental factors may clarify the underlying disease mechanism. Hence, we tested whether body mass index (BMI) modified the genetic association of the apolipoprotein E ε4 allele with cognitive decline. The data came from a longitudinal population-based sample of 4055 participants interviewed at 3-year intervals from 1993 to 2012. Cognitive function was assessed using a standardized global cognitive score and BMI was assessed at baseline and classified as normal, overweight, and obese. There were 1374 (34%) participants with the ε4 allele. In normal BMI participants, cognitive decline was 0.048 units/y without the ε4 allele, and increased by an additional 0.031 units/y with the ε4 allele. In overweight participants, cognitive decline was 0.038 units/y without the ε4 allele, and increased by an additional 0.026 units/y with the ε4 allele. Finally, in obese participants, cognitive decline was 0.038 units/y without the ε4 allele, and increased by an additional 0.014 units/y with the ε4 allele. The association of ε4 allele with cognitive decline was significantly lower in obese participants compared with normal BMI participants (P=0.003), thereby suggesting significant gene-environment interaction on cognitive decline.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24145695      PMCID: PMC4002654          DOI: 10.1097/WAD.0000000000000013

Source DB:  PubMed          Journal:  Alzheimer Dis Assoc Disord        ISSN: 0893-0341            Impact factor:   2.703


  23 in total

1.  Cognitive activity and incident AD in a population-based sample of older persons.

Authors:  R S Wilson; D A Bennett; J L Bienias; N T Aggarwal; C F Mendes De Leon; M C Morris; J A Schneider; D A Evans
Journal:  Neurology       Date:  2002-12-24       Impact factor: 9.910

2.  Apolipoprotein E genotyping by one-stage PCR.

Authors:  P R Wenham; W H Price; G Blandell
Journal:  Lancet       Date:  1991-05-11       Impact factor: 79.321

3.  Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI.

Authors:  J E Hixson; D T Vernier
Journal:  J Lipid Res       Date:  1990-03       Impact factor: 5.922

4.  Obesity: preventing and managing the global epidemic. Report of a WHO consultation.

Authors: 
Journal:  World Health Organ Tech Rep Ser       Date:  2000

5.  Prevalence of Alzheimer's disease in a community population of older persons. Higher than previously reported.

Authors:  D A Evans; H H Funkenstein; M S Albert; P A Scherr; N R Cook; M J Chown; L E Hebert; C H Hennekens; J O Taylor
Journal:  JAMA       Date:  1989-11-10       Impact factor: 56.272

6.  Relation between body mass index and cognitive function in healthy middle-aged men and women.

Authors:  M Cournot; J C Marquié; D Ansiau; C Martinaud; H Fonds; J Ferrières; J B Ruidavets
Journal:  Neurology       Date:  2006-10-10       Impact factor: 9.910

7.  Education modifies the effect of apolipoprotein epsilon 4 on cognitive decline.

Authors:  Marie-Florence Shadlen; Eric B Larson; Li Wang; Elizabeth A Phelan; Wayne C McCormick; Lance Jolley; Linda Teri; Gerald van Belle
Journal:  Neurobiol Aging       Date:  2005-01       Impact factor: 4.673

8.  Apolipoprotein E genotypes and cognitive functions in healthy elderly persons.

Authors:  H B Staehelin; P Perrig-Chiello; C Mitrache; A R Miserez; W J Perrig
Journal:  Acta Neurol Scand       Date:  1999-07       Impact factor: 3.209

9.  Use of brief cognitive tests to identify individuals in the community with clinically diagnosed Alzheimer's disease.

Authors:  M Albert; L A Smith; P A Scherr; J O Taylor; D A Evans; H H Funkenstein
Journal:  Int J Neurosci       Date:  1991-04       Impact factor: 2.292

10.  Body mass index and cognitive decline in mild cognitive impairment.

Authors:  Benjamin B Cronk; David K Johnson; Jeffrey M Burns
Journal:  Alzheimer Dis Assoc Disord       Date:  2010 Apr-Jun       Impact factor: 2.703

View more
  12 in total

Review 1.  Mitochondrial dysfunction and cell death in neurodegenerative diseases through nitroxidative stress.

Authors:  Mohammed Akbar; Musthafa Mohamed Essa; Ghazi Daradkeh; Mohamed A Abdelmegeed; Youngshim Choi; Lubna Mahmood; Byoung-Joon Song
Journal:  Brain Res       Date:  2016-02-13       Impact factor: 3.252

Review 2.  Gene-by-environment interactions in Alzheimer's disease and Parkinson's disease.

Authors:  Amy R Dunn; Kristen M S O'Connell; Catherine C Kaczorowski
Journal:  Neurosci Biobehav Rev       Date:  2019-06-14       Impact factor: 8.989

3.  Lower Late-Life Body-Mass Index is Associated with Higher Cortical Amyloid Burden in Clinically Normal Elderly.

Authors:  David C Hsu; Elizabeth C Mormino; Aaron P Schultz; Rebecca E Amariglio; Nancy J Donovan; Dorene M Rentz; Keith A Johnson; Reisa A Sperling; Gad A Marshall
Journal:  J Alzheimers Dis       Date:  2016-06-18       Impact factor: 4.472

4.  Body Mass Index and Decline in Cognitive Function in Older Black and White Persons.

Authors:  Zoe Arvanitakis; Ana W Capuano; David A Bennett; Lisa L Barnes
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2018-01-16       Impact factor: 6.053

5.  Body Mass Index and Polygenic Risk for Alzheimer's Disease Predict Conversion to Alzheimer's Disease.

Authors:  Jena N Moody; Kate E Valerio; Alexander N Hasselbach; Sarah Prieto; Mark W Logue; Scott M Hayes; Jasmeet P Hayes
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2021-07-13       Impact factor: 6.591

6.  Detecting the genetic link between Alzheimer's disease and obesity using bioinformatics analysis of GWAS data.

Authors:  Qi-Shuai Zhuang; Hao Zheng; Xiao-Dan Gu; Liang Shen; Hong-Fang Ji
Journal:  Oncotarget       Date:  2017-07-08

7.  Obesity Accelerates Alzheimer-Related Pathology in APOE4 but not APOE3 Mice.

Authors:  V Alexandra Moser; Christian J Pike
Journal:  eNeuro       Date:  2017-06-13

8.  Association of plasma ghrelin levels and ghrelin rs4684677 polymorphism with mild cognitive impairment in type 2 diabetic patients.

Authors:  Rong Huang; Jing Han; Sai Tian; Rongrong Cai; Jie Sun; Yanjue Shen; Shaohua Wang
Journal:  Oncotarget       Date:  2017-02-28

Review 9.  APOE Alleles and Diet in Brain Aging and Alzheimer's Disease.

Authors:  Hussein N Yassine; Caleb E Finch
Journal:  Front Aging Neurosci       Date:  2020-06-10       Impact factor: 5.750

10.  Plasma Clusterin and the CLU Gene rs11136000 Variant Are Associated with Mild Cognitive Impairment in Type 2 Diabetic Patients.

Authors:  Rongrong Cai; Jing Han; Jie Sun; Rong Huang; Sai Tian; Yanjue Shen; Xue Dong; Wenqing Xia; Shaohua Wang
Journal:  Front Aging Neurosci       Date:  2016-07-28       Impact factor: 5.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.